Welcome to our dedicated page for Azenta SEC filings (Ticker: AZTA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing a life-science specialist’s disclosures can feel like lab work itself. Azenta Inc’s filings weave together cold-chain logistics, automated storage rollouts, multiomics milestones, and frequent M&A activity—details that easily stretch a 300-page 10-K. If you have ever asked, “How do I find Azenta insider trading Form 4 transactions before the next earnings call?” you are not alone.
Stock Titan solves that problem. Our AI reads every Azenta quarterly earnings report 10-Q filing, flags shifts in segment margins, and translates technical jargon into plain English. Need the latest Azenta Form 4 insider transactions real-time? Get alert-level visibility within seconds. From the Azenta annual report 10-K simplified overview to an 8-K material events explained snapshot, you will see what moved the share price without combing through exhibits.
Investors use the platform to:
- Spot Azenta executive stock transactions Form 4 and compare them to backlog trends.
- Review Azenta proxy statement executive compensation alongside R&D commitments.
- Run an Azenta earnings report filing analysis that highlights sample-storage revenue growth.
- Track each Azenta 8-K material event explained—new lab openings, acquisitions, or leadership changes.
All disclosures arrive in real time as EDGAR posts them, and our AI-powered summaries ensure Azenta SEC filings are explained simply. Whether you are understanding Azenta SEC documents with AI for the first time or diving deep into cold-chain cap-ex tables, Stock Titan keeps you a step ahead and hours richer in research time.
Azenta insider sale tied to RSU vesting. Ginger Zhou, SVP and GM, Multiomics, disposed of 1,085 common shares on 08/12/2025 to satisfy withholding tax obligations arising from the vesting of 3,167 restricted stock units that vested on 08/09/2025. The reported sale price was $28.54 per share.
After the transaction the reporting person beneficially owned 26,831 shares. The Form 4 discloses this as a routine tax-withholding disposition rather than an open-market trading decision.
Azenta insider Olga Pirogova, who serves as SVP and CHRO, reported a disposition of common stock related to tax withholding on vested restricted stock units. The filing shows a sale of 1,085 shares at a reported price of $28.54 executed on 08/12/2025 to satisfy tax withholding obligations arising from the vesting on 08/09/2025 of 3,167 restricted stock units. After the transaction the reporting person beneficially owns 18,288 shares.
This is a routine, compensation-related sale rather than an unsolicited market disposition: the explanatory note explicitly states the sale was to meet withholding tax obligations on vested RSUs. No derivative transactions were reported in the filing.
Lawrence Y. Lin, Azenta's EVP, Chief Financial Officer and Treasurer, reported an open-market purchase of 2,500 common shares on 08/11/2025 at a price of $27.96 per share. After the transaction, his beneficial ownership increased to 46,013 shares.
The filing is a routine Form 4 disclosure showing an insider purchase executed in the open market. The report does not include any derivative transactions or indications of a planned trading program; the explanation provided states simply: "Open market purchase."
Azenta, Inc. filed a Current Report on Form 8-K dated August 5, 2025 announcing via press release its financial results for the fiscal quarter ended June 30, 2025.
The press release is attached as Exhibit 99.1 and the Cover Page Interactive Data File is included as Exhibit 104. The filing states the Item 2.02 disclosure and Exhibit 99.1 are not deemed "filed" under Section 18 of the Exchange Act and contains a cautionary note regarding forward-looking statements. The report was signed by Ephraim Starr, Senior Vice President, General Counsel and Secretary, dated August 5, 2025. This Form 8-K does not include any numerical financial metrics; readers should consult Exhibit 99.1 for the detailed results.
FAQ
What is the current stock price of Azenta (AZTA)?
What is the market cap of Azenta (AZTA)?
